Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1SME

PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A

Summary for 1SME
Entry DOI10.2210/pdb1sme/pdb
Related PRD IDPRD_000557
DescriptorPLASMEPSIN II, Pepstatin (3 entities in total)
Functional Keywordsaspartyl proteinase, aspartic proteinase, aspartyl protease, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourcePlasmodium falciparum (malaria parasite P. falciparum)
More
Cellular locationVacuole: P46925
Total number of polymer chains4
Total formula weight75279.25
Authors
Silva, A.M.,Lee, A.Y.,Gulnik, S.V.,Goldberg, D.E.,Erickson, J.W. (deposition date: 1996-06-11, release date: 1997-01-11, Last modification date: 2024-10-23)
Primary citationSilva, A.M.,Lee, A.Y.,Gulnik, S.V.,Maier, P.,Collins, J.,Bhat, T.N.,Collins, P.J.,Cachau, R.E.,Luker, K.E.,Gluzman, I.Y.,Francis, S.E.,Oksman, A.,Goldberg, D.E.,Erickson, J.W.
Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
Proc.Natl.Acad.Sci.USA, 93:10034-10039, 1996
Cited by
PubMed Abstract: Plasmodium falciparum is the major causative agent of malaria, a disease of worldwide importance. Resistance to current drugs such as chloroquine and mefloquine is spreading at an alarming rate, and our antimalarial armamentarium is almost depleted. The malarial parasite encodes two homologous aspartic proteases, plasmepsins I and II, which are essential components of its hemoglobin-degradation pathway and are novel targets for antimalarial drug development. We have determined the crystal structure of recombinant plasmepsin II complexed with pepstatin A. This represents the first reported crystal structure of a protein from P. falciparum. The crystals contain molecules in two different conformations, revealing a remarkable degree of interdomain flexibility of the enzyme. The structure was used to design a series of selective low molecular weight compounds that inhibit both plasmepsin II and the growth of P. falciparum in culture.
PubMed: 8816746
DOI: 10.1073/pnas.93.19.10034
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon